Neoadjuvant Cisplatin/Docetaxel (CDDP/TXT) and Chemoradiation for Head and Neck Cancer

Clinical trial NCT00982436 · UNKNOWN

Trial details

NCT number: NCT00982436
Sponsor: University of Vermont
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Head and Neck Neoplasms

Start date: 2009-09-01
Primary completion: 2012-09-01
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.